vimarsana.com

Page 198 - லண்டன் பள்ளி ஆஃப் சுகாதாரம் வெப்பமண்டல மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19: Blood clot reports in Europe prompt investigation into Oxford-AstraZeneca vaccine

COVID-19: Blood clot reports in Europe prompt investigation into Oxford-AstraZeneca vaccine
iwradio.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iwradio.co.uk Daily Mail and Mail on Sunday newspapers.

Denmark, Norway and Iceland suspend AstraZeneca COVID shots after blood clot reports

Health authorities in Denmark, Norway and Iceland on Thursday suspended the use of AstraZeneca's COVID-19 vaccine following reports of the formation of blood clots in some people who had been vaccinated.

Drug Regulator Backs Astra Shot After Italy, Denmark Suspensions

The European Union’s drugs regulator said the benefits of AstraZeneca Plc’s Covid-19 vaccine continue to outweigh its risks, and the shot can still be administered while investigations of possible blood clots are ongoing.

Drug Regulator Backs Astra Shot After Suspensions in Europe

European Regulator Backs Astra Vaccine After Suspensions Bloomberg 3/12/2021 Morten Buttler © Photographer: LISELOTTE SABROE/AFP Medical personnel prepares a syringe for vaccination with the AstraZeneca vaccine at the Region Hovedstaden s vaccine center in Bella Center in Copenhagen. (Bloomberg) The European Union’s drugs regulator said the benefits of AstraZeneca Plc’s Covid-19 vaccine continue to outweigh its risks, and the shot can still be administered while investigations of possible blood clots are ongoing. The European Medicines Agency reiterated that there is currently no indication that the Astra vaccine caused these conditions, which aren’t listed as side effects. The EMA issued the statement as Denmark, Italy and Norway joined other European countries in temporarily suspending use of some or all of their Astra Covid shots. The regulator is investigating the concerns.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.